Yi Ba

21.9k citations
202 papers · 17.0k · 10 hit papers · h-index 51

Impact in

    • MicroRNA in disease regulation
  • Oncology top 1%
    • Cancer Immunotherapy and Biomarkers
    • Colorectal Cancer Treatments and Studies

Papers in

    • Colorectal Cancer Treatments and Studies 20
    • Cancer Immunotherapy and Biomarkers 13
    • MicroRNA in disease regulation 33

Yi Ba

188 papers receiving 16.6k citations

Yi Ba's Hit Papers

First-line cadonilimab plus chemotherapy in HER2-negative advanced gastric or gastroesophageal junction adenocarcinoma: a randomized, double-blind, phase 3 trial 2025 · 56 citations
560+6+12Years since publication10002.0k3.0k4.0k

Peers

Yi Ba
Comparison fields: 5 of 114
  • Cancer Research 4.5k
  • Oncology 1.7k
  • Molecular Biology 3.3k
  • Pulmonary and Respiratory Medicine 1.5k
  • Surgery 886
Replace Gu Kong with:
Gu Kong South Korea
Min Yan China
Dimitrios Iliopoulos Greece
Jun Chen China
Bingya Liu China
Kazuaki Takabe United States
Dongxin Lin China
Klaus Jung Germany
Jian Hong Gu United States
Lin Li China
Yi Ba relative to Gu Kong South Korea Gu Kong's profile →
Citations per field
00.5×1.5×2.2×
Gu Kong · 1×
Citations per year

Countries citing papers authored by Yi Ba

Since Specialization
Citations

This map shows the geographic impact of Yi Ba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi Ba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi Ba more than expected).

Fields of papers citing papers by Yi Ba

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yi Ba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi Ba. The network helps show where Yi Ba may publish in the future.

Co-authors

The 25 scholars most cited alongside Yi Ba, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Yi Ba Line = papers co-authored together Yi Ba links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 202 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases
Hit paper breakdown →
20084008
2
Secreted Monocytic miR-150 Enhances Targeted Endothelial Cell Migration
Hit paper breakdown →
20101045
3
Exogenous plant MIR168a specifically targets mammalian LDLRAP1: evidence of cross-kingdom regulation by microRNA
Hit paper breakdown →
2011991
4
CAF secreted miR-522 suppresses ferroptosis and promotes acquired chemo-resistance in gastric cancer
Hit paper breakdown →
2020844
5
Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Apatinib in Patients With Chemotherapy-Refractory Advanced or Metastatic Adenocarcinoma of the Stomach or Gastroesophageal Junction
Hit paper breakdown →
2016807
6
Effect of Camrelizumab vs Placebo Added to Chemotherapy on Survival and Progression-Free Survival in Patients With Advanced or Metastatic Esophageal Squamous Cell Carcinoma
Hit paper breakdown →
2021564
7 2009493
8
Camrelizumab versus investigator's choice of chemotherapy as second-line therapy for advanced or metastatic oesophageal squamous cell carcinoma (ESCORT): a multicentre, randomised, open-label, phase 3 study
Hit paper breakdown →
2020490
9 2017476
10
Exosome‐delivered circRNA promotes glycolysis to induce chemoresistance through the miR‐122‐PKM2 axis in colorectal cancer
Hit paper breakdown →
2020435
11 2019372
12 2010366
13 2011342
14 2011248
15
Adipocyte‐Derived Exosomal MTTP Suppresses Ferroptosis and Promotes Chemoresistance in Colorectal Cancer
Hit paper breakdown →
2022189
16 2018186
17 2020167
18 2021165
19 2014149
20 2021136

About Yi Ba

Yi Ba is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Surgery and Physiology, having authored 202 papers that have together received 17.0k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (33 papers), Colorectal Cancer Treatments and Studies (20 papers), Gastric Cancer Management and Outcomes (20 papers), Cancer Immunotherapy and Biomarkers (13 papers), Esophageal Cancer Research and Treatment (11 papers), Extracellular vesicles in disease (10 papers), Nutrition and Health in Aging (9 papers) and Ferroptosis and cancer prognosis (4 papers). The work is most often cited by research in Cancer Research (4.5k citations), Oncology (1.7k citations), Molecular Biology (3.3k citations), Pulmonary and Respiratory Medicine (1.5k citations) and Surgery (886 citations). Yi Ba has collaborated with scholars based in China, Japan and United States. Frequent co-authors include Ting Deng, Haiyang Zhang, Guoguang Ying, Haiou Yang, Jialu Li, Tao Ning, Shaohua Ge, Tao Ning, Rui Liu and Xi Chen. Their work appears in journals such as BMC Cancer, 癌症:英文版, Annals of Oncology, Cancer Biology and Medicine and Cancer Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact